All the news Showing 10 of 53 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Antiviral treatments for hepatitis B may reduce severity of COVID-19 or risk of infection Keith Alcorn / 25 June 2021 People taking tenofovir (Viread) as treatment for hepatitis B were significantly less likely to suffer severe COVID-19 or to need mechanical ventilation after admission to hospital than people taking the alternative hepatitis B ... Undertreated HCV During COVID-19 Seen Increasing Global Liver-Related Deaths Gastroenterology & Endoscopy News / 21 June 2021 COVID-19 reduced US hepatitis C testing, diagnosis and treatment Keith Alcorn / 21 May 2021 The COVID-19 pandemic severely reduced hepatitis C testing, diagnosis and treatment in the United States during 2020, a study by Quest Diagnostics and the US Centers for Disease Control and Prevention (CDC) ... New Findings Suggest Hepatitis C Drugs May Multiply Effect of COVID-19 Antiviral Remdesivir Pharmacy Times / 21 May 2021 Outreach to homeless in England achieved large-scale testing for hepatitis C during the COVID-19 lockdown Keith Alcorn / 25 March 2021 Outreach to homeless people in England housed in temporary accommodation during the COVID-19 pandemic led to over 1200 to be tested for hepatitis C, one in ten to test positive for active ... Harnessing the COVID-19 Response Towards Hepatitis C Elimination Treatment Action Group / 22 February 2021 COVID-19 slows viral hepatitis elimination, global survey finds Keith Alcorn / 22 February 2021 COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ... COVID-19 hits viral hepatitis care for vulnerable populations The Lancet / 22 February 2021 Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Will people with liver disease be prioritised for COVID-19 vaccination? Keith Alcorn / 19 January 2021 People with decompensated cirrhosis should be prioritised for COVID-19 vaccination and immunosuppressive treatment after a liver transplant should not be a barrier to vaccination, an international panel of liver experts has concluded. Their review ... ← Prev12345...6Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive